Kanbi  Pharma  Teknoloji  Limite
1642288-47-8 Mavacamten
1642288-47-8 Mavacamten
1642288-47-8 Mavacamten

1642288-47-8 Mavacamten

CAS: 1642288-47-8
MF: C15H19N3O2
MW: 273.33
Einecs: 213-161-7
MDL No.:MFCD31746877

Voye rechèch
Dekri teren

Pwopriyete

Aparans blan nan koupe-blan solid
Dansite 1.19 ± 0. 1 g/cm3
solubility solubl nan H2O; Pi gran pase oswa egal a 11.32 mg/ml nan EtOH ak ultrasons; Pi gran pase oswa egal a 13.65 mg/ml nan DMSO
PKA8.83 ± 0. 40

 

Aplikasyon:

Mavacamten se yon ti dwòg molekil ki itilize pou trete kadyomiopati ipèrtrofik blokis (HCM), ki diminye ipèrtrofi myokad ak amelyore fonksyon kadyak pa anpeche fonksyon an nan myofibril myofibril fòme anzim (myosin)

 

Sinonim:

Mavacamten

1642288-47-8

Camzyos

Myk -461

Sar -439152

6- [[(1s) -1- phenylethyl] amino] -3- propan -2- yl -1 h-pyrimidine -2, 4-}}}}}}}} {

2,4 (1H, 3H) -pyrimidinedione, 3- (1- methylethyl) -6- (((1s) -1- feniletil) amino)-

6- (((1s) -1- phenylethyl) amino) -3- (propan -2- yl) -1, 2,3,4 tetrahydropyrimidine {{9}

6- [[(1 ~ {s}) -1- phenylethyl] amino] -3- propan -2- yl -1 ~ {}}}} {

(S) -3- izopropil -6- ((1- feniletil) amino) Pyrimidine -2, 4 (1h, 3h) -dione

mavacamtenum

2,4 (1H, 3H) -pyrimidinedione, 3- (1- methylethyl) -6- [[(1s) -1- feniletil] amino]-

3- (1- methylethyl) -6- (((1s) -1- phenylethyl) amino) -2, 4 (1h, 3h) -pyrimidinedione

6- (((1s) -1- phenylethyl) amino) -3- (propan -2- yl) Pyrimidine -2, 4 (1h, 3h) -dione

Camzyos

Mavacamten

 

Baj popilè: 1642288-47-8 Mavacamten, Lachin 1642288-47-8 Mavacamten Manifaktirè, Swèd

Inquiry
goTop

(0/10)

clearall